{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:52:39Z","timestamp":1781023959219,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,8]]},"DOI":"10.7759\/cureus.13766","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T16:39:31Z","timestamp":1615221571000},"source":"Crossref","is-referenced-by-count":21,"title":["Assessing Consistency of Drug-Drug Interaction-Related Information Across Various Drug Information Resources"],"prefix":"10.7759","author":[{"given":"Atiqulla","family":"Shariff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik","family":"Belagodu Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelu Farhath","family":"Abdullah Basha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamma Sulaiman Hasan","family":"Bin Taleth Alshemeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora Adel","family":"Ahmed Aljallaf Alzaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Drug interactions","author":"Ferguson R","year":"2012","unstructured":"Ferguson R. Drug interactions. A Textbook of Clinical Pharmacy Practice: Essential Concepts and Skills. Parthasarathi G, Nyfort-Hansen K, Nahata MC (ed): Orient Longman Pvt. Ltd., Chennai, India; 2012. 123-39."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/2279-042X.192461","article-title":"A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness","volume":"5","author":"Kheshti R","year":"2016","unstructured":"Kheshti R, Aalipour M, Namazi S. A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016, 5:257-63. 10.4103\/2279-042X.192461","journal-title":"J Res Pharm Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3592","article-title":"Hospital admissions\/visits associated with drug-drug interactions: a systematic review and meta-analysis","volume":"23","author":"Dechanont S","year":"2014","unstructured":"Dechanont S, Maphanta S, Butthum B, Kongkaew C. Hospital admissions\/visits associated with drug-drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2014, 23:489-97. 10.1002\/pds.3592","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocw183","article-title":"Meaningful use of health information technology and declines in in-hospital adverse drug events","volume":"24","author":"Furukawa MF","year":"2017","unstructured":"Furukawa MF, Spector WD, Limcangco MR, Encinosa WE. Meaningful use of health information technology and declines in in-hospital adverse drug events. J Am Med Inform Assoc. 2017, 24:729-36. 10.1093\/jamia\/ocw183","journal-title":"J Am Med Inform Assoc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18433\/j35c7z","article-title":"Drug-drug interactions associated with length of stay and cost of hospitalization","volume":"12","author":"Moura CS","year":"2009","unstructured":"Moura CS, Acurcio FA, Belo NO. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009, 12:266-72. 10.18433\/j35c7z","journal-title":"J Pharm Pharm Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033236","article-title":"Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - a meta-analysis","volume":"7","author":"Hakkarainen KM","year":"2012","unstructured":"Hakkarainen KM, Hedna K, Petzold M, H\u00e4gg S. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - a meta-analysis. PLoS One. 2012, 7:33236. 10.1371\/journal.pone.0033236","journal-title":"PLoS One"},{"key":"ref7","unstructured":"FDA. Preventable adverse drug reactions. a focus on drug interactions. (2018). Accessed: November 21, 2020: https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/preventable-adverse-drug-reactions-focus-drug-interactions."},{"key":"ref8","article-title":"Comparing drug-drug interaction severity ratings between bedside clinicians and proprietary databases","volume":"2013","author":"Armahizer MJ","year":"2013","unstructured":"Armahizer MJ, Kane-Gill SL, Smithburger PL, Anthes AM, Seybert AL. Comparing drug-drug interaction severity ratings between bedside clinicians and proprietary databases. Int Sch Res Notices. 2013, 2013:347346.","journal-title":"Int Sch Res Notices"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocx010","article-title":"Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support","volume":"24","author":"Fung KW","year":"2017","unstructured":"Fung KW, Kapusnik-Uner J, Cunningham J, Higby-Baker S, Bodenreider O. Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support. J Am Med Inform Assoc. 2017, 24:806-12. 10.1093\/jamia\/ocx010","journal-title":"J Am Med Inform Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4172\/2167-1052.1000115","article-title":"Comparing drug-drug interaction severity for clinician opinion to proprietary databases","volume":"1","author":"Armahizer MJ","year":"2012","unstructured":"Armahizer MJ, Kane-Gill SL, Smithburger PL, Anthes AM, Seybert AL. Comparing drug-drug interaction severity for clinician opinion to proprietary databases. Adv Pharmacoepidemiol Drug Saf. 2012, 1:1-4. 10.4172\/2167-1052.1000115","journal-title":"Adv Pharmacoepidemiol Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0975-1483.66807","article-title":"Drug interaction and pharmacist","volume":"2","author":"Ansari J","year":"2010","unstructured":"Ansari J. Drug interaction and pharmacist. J Young Pharm. 2010, 2:326-31. 10.4103\/0975-1483.66807","journal-title":"J Young Pharm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3163\/1536-5050.104.4.007","article-title":"Evaluation of resources for analyzing drug interactions","volume":"104","author":"Patel RI","year":"2016","unstructured":"Patel RI, Beckett RD. Evaluation of resources for analyzing drug interactions. J Med Libr Assoc. 2016, 104:290-5. 10.3163\/1536-5050.104.4.007","journal-title":"J Med Libr Assoc"},{"key":"ref13","unstructured":"Truven Health Analytics, Inc. Drug interactions. (2018). Accessed. February 10, 2020: https:\/\/www.micromedexsolutions.com\/home\/dispatch\/ssl\/true."},{"key":"ref14","unstructured":"Portable Electronic Physician Information Database, LLC. Drug interactions. (2018). Accessed. February 2, 2020: https:\/\/www.pepidconnect.com\/."},{"key":"ref15","unstructured":"Drug Interactions. Lexicomp. Wolters Kluwer Health, Inc. Drug interactions. (2018). Accessed. February 15, 2020: http:\/\/online.lexi.com."},{"key":"ref16","unstructured":"WedMD LLC. Medscape drug interaction checker. (1994-2020). Accessed. February 18, 2020: https:\/\/reference.medscape.com\/drug-interactionchecker."},{"key":"ref17","unstructured":"Drugsite Trust. Drugs.com drug interaction checker. (2000-2020). Accessed. February 20, 2020: https:\/\/drugs.com\/drug_interactions.html."},{"key":"ref18","article-title":"Stockley\u2019s Drug Interactions","year":"2010","unstructured":"Stockley\u2019s Drug Interactions. Baxter K (ed). The Pharmaceutical Press, London, UK; 2010."},{"key":"ref19","article-title":"Drug interactions analysis & management: facts and comparisons 2014","author":"Hansten PD","year":"2014","unstructured":"Hansten PD, Horn JR. Drug interactions analysis & management: facts and comparisons 2014. Lippincott Williams and Wilkins, Philadelphia, USA; 2014."},{"key":"ref20","article-title":"","author":"Joint Formulary Committee","year":"2018","unstructured":"Joint Formulary Committee. British National Formulary, 76th ed.. British Medical Association and Royal Pharmaceutical Society of Great Britain, London, UK; 2018."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.03.041","article-title":"A comparison of potential psychiatric drug interactions from six drug interaction database programs","volume":"275","author":"Monteith S","year":"2019","unstructured":"Monteith S, Glenn T. A comparison of potential psychiatric drug interactions from six drug interaction database programs. Psychiatry Res. 2019, 275:366-72. 10.1016\/j.psychres.2019.03.041","journal-title":"Psychiatry Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1086-4","article-title":"Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources","volume":"67","author":"Martins MAP","year":"2011","unstructured":"Martins MAP, Carlos PPS, Ribeiro DD, Nobre VA, C\u00e9sar CC, Rocha MOC, Ribeiro ALP. Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources. Eur J Clin Pharmacol. 2011, 67:1301-8. 10.1007\/s00228-011-1086-4","journal-title":"Eur J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.95","article-title":"Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium","volume":"86","author":"Anthony M","year":"2009","unstructured":"Anthony M, Romero K, Malone DC, Hines LE, Higgins L, Woosley RL. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. Clin Pharmacol Ther. 2009, 86:425-9. 10.1038\/clpt.2009.95","journal-title":"Clin Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200506020-00005","article-title":"Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatological drugs","volume":"6","author":"Chao SD","year":"2005","unstructured":"Chao SD, Maibach HI. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatological drugs. Am J Clin Dermatol. 2005, 6:105-11. 10.2165\/00128071-200506020-00005","journal-title":"Am J Clin Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2015.02.009","article-title":"Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels","volume":"44","author":"Ekstein D","year":"2015","unstructured":"Ekstein D, Tirosh M, Eyal Y, Eyal S. Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels. Epilepsy Behav. 2015, 44:218-24. 10.1016\/j.yebeh.2015.02.009","journal-title":"Epilepsy Behav"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L255","article-title":"Clinically significant drug\u2010drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia","volume":"42","author":"Wong CM","year":"2008","unstructured":"Wong CM, Ko Y, Chan A. Clinically significant drug\u2010drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. Ann Pharmacother. 2008, 42:1737-48. 10.1345\/aph.1L255","journal-title":"Ann Pharmacother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.07.008","article-title":"Consistency of psychotropic drug-drug interactions listed in drug monographs","volume":"57","author":"Liu X","year":"2017","unstructured":"Liu X, Hatton RC, Zhu Y, Hincapie-Castillo JM, Bussing R, Barnicoat M, Winterstein AG. Consistency of psychotropic drug-drug interactions listed in drug monographs. J Am Pharm Assoc. 2017, 57:698-703. 10.1016\/j.japh.2017.07.008","journal-title":"J Am Pharm Assoc"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(00)80036-3","article-title":"Disagreement among drug compendia on inclusion and ratings of drug-drug interactions","volume":"61","author":"Fulda TR","year":"2000","unstructured":"Fulda TR, Valuck RJ, Vander Zanden J, Parker S, Byrns PJ. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions. Curr Ther Res. 2000, 61:540-8. 10.1016\/S0011-393X(00)80036-3","journal-title":"Curr Ther Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02809.x","article-title":"Comparative assessment of four drug interaction compendia","volume":"63","author":"Vitry AI","year":"2007","unstructured":"Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2007, 63:709-14. 10.1111\/j.1365-2125.2006.02809.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1331\/154434504773062582","article-title":"Concordance of severity ratings provided in four drug interaction compendia","volume":"44","author":"Abarca J","year":"2004","unstructured":"Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc. 2004, 44:136-41. 10.1331\/154434504773062582","journal-title":"J Am Pharm Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/47593-assessing-consistency-of-drug-drug-interaction-related-information-across-various-drug-information-resources","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:33Z","timestamp":1707507033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/47593-assessing-consistency-of-drug-drug-interaction-related-information-across-various-drug-information-resources"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.13766","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}